Merkel cell carcinoma (MCC) is a rare and deadly neuroendocrine skin tumor
frequently associated with clonal integration of a polyomavirus, MCPyV, and MCC tumor
cells express putative polyomavirus oncoproteins small T antigen (sTAg) and truncated
large T antigen (tLTAg). Here, we show robust transforming activity of sTAg in
vivo in a panel of transgenic mouse models. Epithelia of pre-term
sTAg-expressing embryos exhibited hyperplasia, impaired differentiation, increased
proliferation and apoptosis, and activation of a DNA damage response. Epithelial
transformation did not require sTAg interaction with the PP2A protein complex, a tumor
suppressor in some other polyomavirus transformation models, but was strictly dependent on
a recently-described sTAg domain that binds Fbxw7, the substrate-binding component of the
SCF ubiquitin ligase complex. Postnatal induction of sTAg using a Cre-inducible transgene
also led to epithelial transformation with development of lesions resembling squamous cell
carcinoma in situ and elevated expression of Fbxw7 target proteins. Our
data establish that expression of MCPyV sTAg alone is sufficient for rapid neoplastic
transformation in vivo, implicating sTAg as an oncogenic driver in MCC
and perhaps other human malignancies. Moreover, the loss of transforming activity
following mutation of the sTAg Fbxw7 binding domain identifies this domain as crucial for in
vivo transformation.
Patient psychological distress is associated with many aspects of the bone marrow transplantation (BMT) process and has been linked with poor treatment outcomes. We assessed psychological distress in potential BMT candidates, and compared patient and nurse coordinator ratings of emotional distress at the time of initial BMT consultation. Fifty patients self-reported psychological distress using both the NCCN Distress Thermometer (DT) and the Hospital Anxiety and Depression Scale (HADS). Coordinators rated patient emotional distress using the DT and Coordinator Rating Scales that measure anxiety and depression. Fifty and 51% of patients self-reported clinically significant levels of emotional distress and anxiety, respectively, but only 20% self-reported clinically significant levels of depression. There was good correlation between ratings using the brief DT and the more comprehensive HADS. There was significant but only moderate agreement between patient and coordinator ratings of emotional distress and anxiety, with coordinators underestimating the number of patients with high levels of emotional distress. In addition, coordinator ratings of patient emotional distress primarily reflected anxiety, whereas anxiety and depression together only minimally accounted for patient self-reports of psychological distress. These findings suggest that: (1) the DT can be a useful screening device; (2) approximately half of patients at the time of initial consultation for BMT already experience significant levels of psychological distress; and (3) coordinators observe emotional distress primarily as anxiety, but patients experience psychological distress as something more than anxiety and depression.
Treatment with anti-osteoporotic therapy after a fragility fracture leads to a 40% decrease in the three-year risk of subsequent fracture, when adjusted for age and sex. Initiation of anti-osteoporotic therapy following a fragility fracture can prevent a subsequent fracture over the following three years in approximately one of every twenty-seven patients treated.
Merkel cell carcinoma (MCC), a rare but aggressive cutaneous neoplasm with high metastatic potential, has a poor prognosis at late stages of disease with no proven chemotherapeutic regimens. Using an enriched culture medium, we established and characterized 11 MCC cell lines for Bcl-2 family profiling and functional studies. Immunoblot analysis revealed collectively high protein levels of pro-survival Bcl-2 members in cell lines and a panel of MCC tumors. Down-regulation of individual Bcl-2 proteins by RNAi promoted death in a subset of MCC cell lines, whereas simultaneous inhibition of multiple family members using the small molecule antagonist ABT-263 led to dramatic induction of cell death in 10 of 11 lines. ABT-263 induced Bax-dependent apoptosis with rapid cleavage of caspase-3 and PARP, regardless of Bcl-2 family profile or presence of Merkel cell polyomavirus. Furthermore, ABT-263 treatment led to rapid and sustained growth suppression of MCC xenografts from a representative cell line, accompanied by a striking increase in apoptosis. Our results establish that concurrent inhibition of multiple pro-survival Bcl-2 proteins leads to effective induction of apoptosis, and strongly support the concept that targeting MCC addiction to these molecules may be useful therapeutically by reversing an intrinsic resistance to cell death.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.